Editor's Note: Welcome to Love It or Hate It, a regular dual-column feature that will capture the love-hate relationship America has with some of its biggest, most controversial companies. For past c

Old school Minyans might recognize the title of this column. It was used in January 2005 after a spiritual awakening in Arizona. When I walked into the desert that day, I operated from a place of fin

Will Trade for FoodGreetings from Hoover-ville where our numbers are few but our spirits are high. The latter is something of a problem, actually, as generating critical Hobo Mass is going to require

Hey buddy, can you spare a wheel of Parmigiano-Reggiano? Italy is in the throes of its fourth recession since 2002, with the country’s economy expected to contract 5.3% this year. And, for many

Leerink Swann has been the loudest supporter of Human Genome Sciences (HGSI). The boutique is now saying the biggest impediment to HGSI becoming the next big-cap biotech -- presumably a la Amgen (AMG

My 14-year-old daughter, Alana, has to have her coffee ice cream, and only the finest: Haagen-Dazs -- twice as rich and twice as expensive as most brands out there.But one day this summer, when my hu

New York attorney general Andrew Cuomo is getting what he wants out of his latest report on Wall Street's bonuses: lots of attention. Here's what he's not getting: Props for offering a solution to th

We’ve all heard urban legends of successful people who became inspired and traded their careers for a life dedicated to helping others. There’s the faceless dot-com whiz who banked in the

From the 2002 bottom to the 2007 market top, it was hard to go wrong no matter what you did. Everything from junk bonds to commodities to emerging markets to the major market indices were all headed

“Now I don't have to tell you good folks what's been happening in our beloved little town. Sheriff murdered, crops burned, stores looted, people stampeded, and cattle raped. The time has come t